Reference library · updated 27 October 2026

Eye Health Library: What Actually Helps Your Eyes

Symptoms first, conditions second, marketing last. Eleven guides written to the same evidence standard we apply to product research.

Quick answer

What this library is
Eleven evidence-based guides to the eye problems people search for most, from screen fatigue to amblyopia.
What it is not
A diagnosis. Symptoms that are new, painful or one-sided need clinical assessment.
Most common complaint
Tired, dry, irritated eyes after screen work — usually tear film and focus fatigue, not damage.
Most common serious condition
Glaucoma, because it is silent until advanced; screening matters more than symptoms.
Best-evidence prevention
Blood-sugar control, smoking cessation, UV protection, screening, and treated sleep apnoea.
Supplements
Nutrition supports eye health, but no pill substitutes for screening or corrects refractive error.

Eye health content online tends either to terrify people with lists of diseases or to sell them something. We wanted neither. This library explains what each common eye problem actually is, what causes it, what genuinely helps, and when a symptom stops being a lifestyle annoyance and becomes a reason to be seen the same day.

Every article is written against the same evidentiary standard we apply to product research: separate what is established from what is preliminary, distinguish treatment from support, and be explicit about the limits of nutrition in a field where surgery, lenses and medication do most of the work.

Start with your symptom

Most people arrive with a symptom rather than a diagnosis, so the library is ordered that way. Tired eyes and blurry vision sit near the top because they are common and usually benign; a vision deficiency present since childhood, or blindness and vision impairment from progressive disease, sits further down, where the stakes are higher and self-management stops being the answer.

Named conditions

Everyday eye health

Where supplements fit

Supplements have a narrow, real role in eye health — narrower than the market implies. The strongest evidence concerns specific nutrients in specific populations, most famously the AREDS2 formulation for people with intermediate age-related macular degeneration. It does not extend to "improving eyesight" in healthy adults, and it certainly does not extend to reversing a prescription.

Two things supplements cannot do: correct refractive error, and treat glaucoma, cataract or diabetic retinopathy. If a product promises either, that tells you what you need to know about the product.

What nutrition and supplementation can and cannot do for eyes
GoalWhat the evidence supportsWhat it does not
Slow progression of intermediate AMDAREDS2-type antioxidant plus lutein/zeaxanthin formulaRestoring lost vision, or helping people without AMD
Reduce dry-eye symptomsOmega-3 in some people, lubricant drops, lid hygieneCuring aqueous-deficient dry eye
General retinal nutritionA diet rich in leafy greens, colourful vegetables and oily fishA daily pill replacing a poor diet
Correct short or long sightednessNothing nutritionalAny supplement, ever
Lower intraocular pressurePrescription drops, laser, surgeryAny over-the-counter product

For readers researching a specific product, our EyeFortin ingredient analysis applies the same standard ingredient by ingredient, and the full review explains where the marketing outruns the evidence.

When to seek care urgently

Six symptoms that should not wait for a routine appointment.

  • Sudden loss or blurring of vision in one eye
  • A curtain or shadow across part of the visual field
  • A sudden shower of floaters, especially with flashes of light
  • Eye pain with redness and reduced vision
  • Sudden double vision, or vision loss with weakness or speech difficulty
  • New distortion where straight lines look bent

Each of those maps to a condition where hours matter. None is a supplement question, and none should be researched for a week first.

References

  1. GBD 2019 Blindness and Vision Impairment Collaborators. Trends in prevalence of blindness and distance and near vision impairment over 30 years. The Lancet Global Health. 2021;9(2):e130–e143. Source
  2. Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II epidemiology report. The Ocular Surface. 2017;15(3):334–365. Source
  3. Rosenfield M. Computer vision syndrome: a review of ocular causes and potential treatments. Ophthalmic and Physiological Optics. 2011;31(5):502–515. Source
  4. Morgan IG, Ohno-Matsui K, Saw SM. Myopia. The Lancet. 2012;379(9827):1739–1748. Source
  5. Holmes JM, Lazar EL, Melia BM, et al. Effect of age on response to amblyopia treatment in children. Archives of Ophthalmology. 2011;129(11):1451–1457. Source
  6. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Archives of Ophthalmology. 2001;119(10):1417–1436. Source
  7. Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 randomized clinical trial. JAMA. 2013;309(19):2005–2015. Source
  8. National Eye Institute. Glaucoma. Source
  9. National Eye Institute. Cataracts. Source
  10. National Eye Institute. Diabetic retinopathy. Source
  11. National Eye Institute. Age-related macular degeneration (AMD). Source
  12. National Eye Institute. Amblyopia (lazy eye). Source
  13. National Eye Institute. Refractive errors. Source
  14. American Optometric Association. Computer vision syndrome. Source
  15. National Eye Institute. Dry eye. Source

Links open in a new tab. Citations are provided for ingredient and background research only. No published trial has tested the finished EyeFortin formula.